Related Experiment Videos
Nonalcoholic fatty liver disease: a review
1Cedars-Sinai Medical Center, 8635 W. 3rd Street, 590W, Los Angeles, CA 90048, USA. Fred.poordad@cshs.org
Expert Opinion on Emerging Drugs
|August 9, 2005
Summary
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver conditions, from simple steatosis to cirrhosis. Research is actively exploring NAFLD pathogenesis and treatment to alter disease progression.
Area of Science:
- Hepatology
- Gastroenterology
- Internal Medicine
Background:
- Nonalcoholic fatty liver disease (NAFLD) is a spectrum of liver conditions including steatosis, nonalcoholic steatohepatitis, and advanced fibrosis/cirrhosis.
- The term was established to distinguish these from alcohol-related liver disorders due to histological similarities.
- Recent years have seen increased attention on NAFLD due to a better understanding of its prevalence and impact.
Purpose of the Study:
- To review the current understanding of nonalcoholic fatty liver disease.
- To discuss the epidemiology, pathogenesis theories, and available treatment options for NAFLD.
Main Methods:
- Literature review of epidemiological data.
- Analysis of current theories on NAFLD pathogenesis.
- Summary of established and emerging treatment strategies.
Main Results:
- NAFLD is a growing health concern with significant clinical implications.
- Pathogenesis is complex and under extensive investigation.
- Treatment approaches are evolving, targeting various aspects of the disease spectrum.
Conclusions:
- NAFLD represents a significant and complex liver disease requiring further research.
- Understanding the epidemiology and pathogenesis is crucial for developing effective interventions.
- Ongoing research aims to identify novel therapeutic targets to manage NAFLD progression.